Bullboard - Stock Discussion Forum CEL-SCI Corp CVM

Healthcare Biotechnology

CEL-SCI Corporation is a clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system. The Company is focused on the development of product candidates and technologies, such as Multikine, an investigational immunotherapy under development for the potential treatment of certain head and neck... see more

Add To Watchlist

NYSEAM:CVM - Post Discussion

CEL-SCI Corp > CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of

View:

Post by whytestocks on May 08, 2024 10:15am

CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of

JUST IN: $CVM CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck CancerCritical milestone achieved—the FDA accepted CEL-SCI’s selection criteria defining the Multikine target population before surgery Selected patient population had 73% survival with Multikine vs. 45% without Multikine based on analysis of completed 928-patient Phase 3 rand...CVM - CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer